Sunitinib-Containing Carborane Pharmacophore with the Ability to Inhibit Tyrosine Kinases Receptors FLT3, KIT and PDGFR-beta, Exhibits Powerful In Vivo Anti-Glioblastoma Activity

Discover the latest results on carborane as pharmacophore on anti-glioblastoma activity at Cancers 2020, 12, 3423.

This entry was posted in News, Scientific Highlights. Bookmark the permalink.